J&J & Actelion: more mergers for big pharma?

ReutersNewsPublished: November 25, 2016Updated: November 27, 2016
Published: November 25, 2016Updated: November 27, 2016

U.S. healthcare giant Johnson & Johnson is reported to be approaching Swiss biotechnology firm Actelion about a potential takeover. David Pollard reports.

Be the first to suggest a tag

    Comments

    0 comments